Management of Patients with Inflammatory Diseases during the COVID-19 PandemicJoint Position Statement Published on 2020-09-222022-10-31 Journal: Mediterranean Journal of Rheumatology [Category] [DOI] 10.31138/mjr.31.3.295 PMC 바로가기 [Article Type] Joint Position Statement
Kawasaki Disease and COVID-19Review Published on 2020-09-212022-10-31 Journal: Mediterranean Journal of Rheumatology [Category] [DOI] 10.31138/mjr.31.3.268 PMC 바로가기 [Article Type] Review
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic Position paper of Ärzteverband Deutscher Allergologen (AeDA) , Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI) , Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA) , Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI) , Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI) , Österreichische Gesellschaft für Pneumologie (ÖGP) in co-operation with the German, Austrian, and Swiss ARIA groups , and the European Academy of Allergy and Clinical Immunology (EAACI)Research Article Published on 2020-09-072022-10-28 Journal: Allergologie Select [Category] [DOI] 10.5414/ALX02166E PMC 바로가기 [Article Type] Research Article
Bone Metabolism in SARS-CoV-2 Disease: Possible Osteoimmunology and Gender ImplicationsReview Paper Published on 2020-09-012022-10-31 Journal: Clinical Reviews in Bone and Mineral Metabolism [Category] [DOI] 10.1007/s12018-020-09274-3 PMC 바로가기 [Article Type] Review Paper
Vascular endothelial injury exacerbates coronavirus disease 2019: The role of endothelial glycocalyx protectionReview Published on 2020-08-132022-10-30 Journal: Microcirculation (New York, N.Y. : 1994) [Category] [DOI] 10.1111/micc.12654 PMC 바로가기 [Article Type] Review
Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversionArticle Published on 2020-07-242022-10-04 Journal: Nature Communications [Category] [DOI] 10.1038/s41467-020-17703-6 PMC 바로가기 [Article Type] Article
Bioactive Lipids as Mediators of the Beneficial Action(s) of Mesenchymal Stem Cells in COVID-19Opinion Published on 2020-07-232022-10-28 Journal: Aging and Disease [Category] [DOI] 10.14336/AD.2020.0521 PMC 바로가기 [Article Type] Opinion
The rationale of using mesenchymal stem cells in patients with COVID‐19 ‐related acute respiratory distress syndrome: What to expectHuman Clinical Article Published on 2020-07-212022-10-28 Journal: Stem cells translational medicine [Category] [DOI] 10.1002/sctm.20-0164 PMC 바로가기 [Article Type] Human Clinical Article
High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical EffectsImmunology Published on 2020-07-142022-11-01 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2020.01660 PMC 바로가기 [Article Type] Immunology
Role of Autophagy in Lung InflammationImmunology Published on 2020-07-072022-11-01 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2020.01337 PMC 바로가기 [Article Type] Immunology